Officer Dennis Mulroy Files Intent to Sell Additional $585K in Shares, Continuing Recent Sales Pattern
ANAB has more than doubled off its 52-week low of $11.402.
Summary
An officer at AnaptysBio has filed to sell an additional $585,006 in company stock, extending a recent trend of significant share sales by the executive.
Key Events · Ownership and Investor Activity · ANAB
-
Officer Files Intent to Sell
Dennis Mulroy, an officer, filed a Form 144 to sell 10,000 common shares, valued at approximately $585,006.
-
Continuation of Recent Sales
This proposed sale adds to 55,467 shares already sold by Mulroy in the past three months, totaling over $3.3 million in gross proceeds.
-
Acquisition via Option Exercise
The shares intended for sale were acquired through a stock option exercise on the same day as the proposed sale.
-
Context of Repurchase Program
These insider sales occur shortly after AnaptysBio announced a new $100 million share repurchase program on May 12, 2026.
Analysis · ANAB · Life Sciences
Dennis Mulroy, an officer, has filed a Form 144 indicating intent to sell 10,000 shares worth approximately $585,006. This follows a pattern of significant share dispositions by Mulroy, who has already sold 55,467 shares for over $3.3 million in the past three months. The ongoing sales by an executive could be interpreted negatively by investors, especially following the company's recent spin-off and announcement of a $100 million share repurchase program.
At the time of this filing, ANAB was trading at $57.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.